162 related articles for article (PubMed ID: 18381621)
1. Sub one minute inhibition assays for the major cytochrome P450 enzymes utilizing ultra-performance liquid chromatography/tandem mass spectrometry.
Rainville PD; Wheaton JP; Alden PG; Plumb RS
Rapid Commun Mass Spectrom; 2008 May; 22(9):1345-50. PubMed ID: 18381621
[TBL] [Abstract][Full Text] [Related]
2. A rapid ultra-performance liquid chromatography/tandem mass spectrometric methodology for the in vitro analysis of Pooled and Cocktail cytochrome P450 assays.
Alden PG; Plumb RS; Jones MD; Rainville PD; Shave D
Rapid Commun Mass Spectrom; 2010 Jan; 24(1):147-54. PubMed ID: 19960506
[TBL] [Abstract][Full Text] [Related]
3. Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids.
He F; Bi HC; Xie ZY; Zuo Z; Li JK; Li X; Zhao LZ; Chen X; Huang M
Rapid Commun Mass Spectrom; 2007; 21(5):635-43. PubMed ID: 17279482
[TBL] [Abstract][Full Text] [Related]
4. Validated method for rapid inhibition screening of six cytochrome P450 enzymes by liquid chromatography-tandem mass spectrometry.
Li X; Chen X; Li Q; Wang L; Zhong D
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):128-37. PubMed ID: 17267297
[TBL] [Abstract][Full Text] [Related]
5. Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery.
Smith D; Sadagopan N; Zientek M; Reddy A; Cohen L
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):455-63. PubMed ID: 17270503
[TBL] [Abstract][Full Text] [Related]
6. High-throughput cytochrome p450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns.
Peng SX; Barbone AG; Ritchie DM
Rapid Commun Mass Spectrom; 2003; 17(6):509-18. PubMed ID: 12621611
[TBL] [Abstract][Full Text] [Related]
7. Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 microm particle size column.
Petsalo A; Turpeinen M; Pelkonen O; Tolonen A
J Chromatogr A; 2008 Dec; 1215(1-2):107-15. PubMed ID: 19019380
[TBL] [Abstract][Full Text] [Related]
8. High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/on-line guard cartridge extraction/tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolites.
Bu HZ; Magis L; Knuth K; Teitelbaum P
Rapid Commun Mass Spectrom; 2000; 14(17):1619-24. PubMed ID: 10960916
[TBL] [Abstract][Full Text] [Related]
9. Application of a generic fast gradient liquid chromatography tandem mass spectrometry method for the analysis of cytochrome P450 probe substrates.
Ayrton J; Plumb R; Leavens WJ; Mallett D; Dickins M; Dear GJ
Rapid Commun Mass Spectrom; 1998; 12(5):217-24. PubMed ID: 9519475
[TBL] [Abstract][Full Text] [Related]
10. The use of partially porous particle columns for the routine, generic analysis of biological samples for pharmacokinetic studies in drug discovery by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry.
Mallett DN; Ramírez-Molina C
J Pharm Biomed Anal; 2009 Jan; 49(1):100-7. PubMed ID: 19019615
[TBL] [Abstract][Full Text] [Related]
11. Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer.
Castro-Perez J; Plumb R; Granger JH; Beattie I; Joncour K; Wright A
Rapid Commun Mass Spectrom; 2005; 19(6):843-8. PubMed ID: 15723446
[TBL] [Abstract][Full Text] [Related]
12. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
Dasgupta M; Tang W; Caldwell GW; Yan Z
Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.
Qin CZ; Ren X; Tan ZR; Chen Y; Yin JY; Yu J; Qu J; Zhou HH; Liu ZQ
Biomed Chromatogr; 2014 Feb; 28(2):197-203. PubMed ID: 23946123
[TBL] [Abstract][Full Text] [Related]
14. High-throughput cytochrome P450 inhibition assays using laser diode thermal desorption-atmospheric pressure chemical ionization-tandem mass spectrometry.
Wu J; Hughes CS; Picard P; Letarte S; Gaudreault M; Lévesque JF; Nicoll-Griffith DA; Bateman KP
Anal Chem; 2007 Jun; 79(12):4657-65. PubMed ID: 17497828
[TBL] [Abstract][Full Text] [Related]
15. Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design.
Perloff ES; Mason AK; Dehal SS; Blanchard AP; Morgan L; Ho T; Dandeneau A; Crocker RM; Chandler CM; Boily N; Crespi CL; Stresser DM
Xenobiotica; 2009 Feb; 39(2):99-112. PubMed ID: 19255936
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling of endocrine-disrupting compounds by on-line cytochrome p450 bioreaction coupled to on-line receptor affinity screening.
Van Liempd SM; Kool J; Meerman JH; Irth H; Vermeulen NP
Chem Res Toxicol; 2007 Dec; 20(12):1825-32. PubMed ID: 17975887
[TBL] [Abstract][Full Text] [Related]
17. [Simultaneous determination of the inhibitory potency of compounds on the activity of five cytochrome P-450 enzymes using a cocktail probe substrates method].
Gao ZW; Shi XJ; Yu C; Li SJ; Zhong MK
Yao Xue Xue Bao; 2007 Jun; 42(6):589-94. PubMed ID: 17702393
[TBL] [Abstract][Full Text] [Related]
18. Development of three parallel cytochrome P450 enzyme affinity detection systems coupled on-line to gradient high-performance liquid chromatography.
Kool J; van Liempd SM; van Rossum H; van Elswijk DA; Irth H; Commandeur JN; Vermeulen NP
Drug Metab Dispos; 2007 Apr; 35(4):640-8. PubMed ID: 17251308
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of laser diode thermal desorption (LDTD) coupled with tandem mass spectrometry (MS/MS) for support of in vitro drug discovery assays: increasing scope, robustness and throughput of the LDTD technique for use with chemically diverse compound libraries.
Beattie I; Smith A; Weston DJ; White P; Szwandt S; Sealey L
J Pharm Biomed Anal; 2012 Feb; 59():18-28. PubMed ID: 22071442
[TBL] [Abstract][Full Text] [Related]
20. In vitro metabolism of BYZX in human liver microsomes and the structural elucidation of metabolite by liquid chromatography-mass spectrometry method.
Xia ZL; Ying JY; Sheng R; Zeng S; Hu YZ; Yao TW
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):266-74. PubMed ID: 17709305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
